The Preferential Impairment of Pupil Constriction Stimulated by Blue Light in Patients with Type 2 Diabetes without Autonomic Neuropathy

The main aim of the present paper is to examine whether the pupillary light reflex (PLR) mediated by intrinsically photosensitive retinal ganglion cells (ipRGCs) is impaired in type 2 diabetic patients. One hundred and three diabetic patients without diabetic autonomic neuropathy (DAN) and 42 age-ma...

Full description

Saved in:
Bibliographic Details
Main Authors: Fukashi Ishibashi, Rie Kojima, Miki Taniguchi, Aiko Kosaka, Harumi Uetake, Mitra Tavakoli
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2017/6069730
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567487041896448
author Fukashi Ishibashi
Rie Kojima
Miki Taniguchi
Aiko Kosaka
Harumi Uetake
Mitra Tavakoli
author_facet Fukashi Ishibashi
Rie Kojima
Miki Taniguchi
Aiko Kosaka
Harumi Uetake
Mitra Tavakoli
author_sort Fukashi Ishibashi
collection DOAJ
description The main aim of the present paper is to examine whether the pupillary light reflex (PLR) mediated by intrinsically photosensitive retinal ganglion cells (ipRGCs) is impaired in type 2 diabetic patients. One hundred and three diabetic patients without diabetic autonomic neuropathy (DAN) and 42 age-matched controls underwent a series of detailed neurological examinations. The patients were stratified into three groups: stage I, no neuropathy; stage II, asymptomatic neuropathy; stage III, symptomatic but without DAN. The PLR to 470 and 635 nm light at 20 cd/m2 was recorded. Small fiber neuropathy was assessed by corneal confocal microscopy and quantifying corneal nerve fiber (CNF) morphology. The 470 nm light induced a stronger and faster PLR than did 635 nm light in all subjects. The PLR to both lights was impaired equally across all of the diabetic subgroups. The postillumination pupil response (PIPR) after 470 nm light offset at ≥1.7 sec was attenuated in diabetic patients without differences between subgroups. Receiver operating characteristic analysis revealed that the PIPR mediated by ipRGCs in patients with stage II and stage III neuropathy was different from that of the control subjects. Clinical factors, nerve conduction velocity, and CNF measures were significantly correlated with PLR parameters with 470 nm light. PLR kinetics were more impaired by stimulation with blue light than with red light in diabetic patients without DAN.
format Article
id doaj-art-efcabe099eb34ec992d7dada78e20c41
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-efcabe099eb34ec992d7dada78e20c412025-02-03T01:01:25ZengWileyJournal of Diabetes Research2314-67452314-67532017-01-01201710.1155/2017/60697306069730The Preferential Impairment of Pupil Constriction Stimulated by Blue Light in Patients with Type 2 Diabetes without Autonomic NeuropathyFukashi Ishibashi0Rie Kojima1Miki Taniguchi2Aiko Kosaka3Harumi Uetake4Mitra Tavakoli5Ishibashi Clinic, Hiroshima, JapanIshibashi Clinic, Hiroshima, JapanIshibashi Clinic, Hiroshima, JapanIshibashi Clinic, Hiroshima, JapanIshibashi Clinic, Hiroshima, JapanUniversity of Exeter Medical School, Exeter, UKThe main aim of the present paper is to examine whether the pupillary light reflex (PLR) mediated by intrinsically photosensitive retinal ganglion cells (ipRGCs) is impaired in type 2 diabetic patients. One hundred and three diabetic patients without diabetic autonomic neuropathy (DAN) and 42 age-matched controls underwent a series of detailed neurological examinations. The patients were stratified into three groups: stage I, no neuropathy; stage II, asymptomatic neuropathy; stage III, symptomatic but without DAN. The PLR to 470 and 635 nm light at 20 cd/m2 was recorded. Small fiber neuropathy was assessed by corneal confocal microscopy and quantifying corneal nerve fiber (CNF) morphology. The 470 nm light induced a stronger and faster PLR than did 635 nm light in all subjects. The PLR to both lights was impaired equally across all of the diabetic subgroups. The postillumination pupil response (PIPR) after 470 nm light offset at ≥1.7 sec was attenuated in diabetic patients without differences between subgroups. Receiver operating characteristic analysis revealed that the PIPR mediated by ipRGCs in patients with stage II and stage III neuropathy was different from that of the control subjects. Clinical factors, nerve conduction velocity, and CNF measures were significantly correlated with PLR parameters with 470 nm light. PLR kinetics were more impaired by stimulation with blue light than with red light in diabetic patients without DAN.http://dx.doi.org/10.1155/2017/6069730
spellingShingle Fukashi Ishibashi
Rie Kojima
Miki Taniguchi
Aiko Kosaka
Harumi Uetake
Mitra Tavakoli
The Preferential Impairment of Pupil Constriction Stimulated by Blue Light in Patients with Type 2 Diabetes without Autonomic Neuropathy
Journal of Diabetes Research
title The Preferential Impairment of Pupil Constriction Stimulated by Blue Light in Patients with Type 2 Diabetes without Autonomic Neuropathy
title_full The Preferential Impairment of Pupil Constriction Stimulated by Blue Light in Patients with Type 2 Diabetes without Autonomic Neuropathy
title_fullStr The Preferential Impairment of Pupil Constriction Stimulated by Blue Light in Patients with Type 2 Diabetes without Autonomic Neuropathy
title_full_unstemmed The Preferential Impairment of Pupil Constriction Stimulated by Blue Light in Patients with Type 2 Diabetes without Autonomic Neuropathy
title_short The Preferential Impairment of Pupil Constriction Stimulated by Blue Light in Patients with Type 2 Diabetes without Autonomic Neuropathy
title_sort preferential impairment of pupil constriction stimulated by blue light in patients with type 2 diabetes without autonomic neuropathy
url http://dx.doi.org/10.1155/2017/6069730
work_keys_str_mv AT fukashiishibashi thepreferentialimpairmentofpupilconstrictionstimulatedbybluelightinpatientswithtype2diabeteswithoutautonomicneuropathy
AT riekojima thepreferentialimpairmentofpupilconstrictionstimulatedbybluelightinpatientswithtype2diabeteswithoutautonomicneuropathy
AT mikitaniguchi thepreferentialimpairmentofpupilconstrictionstimulatedbybluelightinpatientswithtype2diabeteswithoutautonomicneuropathy
AT aikokosaka thepreferentialimpairmentofpupilconstrictionstimulatedbybluelightinpatientswithtype2diabeteswithoutautonomicneuropathy
AT harumiuetake thepreferentialimpairmentofpupilconstrictionstimulatedbybluelightinpatientswithtype2diabeteswithoutautonomicneuropathy
AT mitratavakoli thepreferentialimpairmentofpupilconstrictionstimulatedbybluelightinpatientswithtype2diabeteswithoutautonomicneuropathy
AT fukashiishibashi preferentialimpairmentofpupilconstrictionstimulatedbybluelightinpatientswithtype2diabeteswithoutautonomicneuropathy
AT riekojima preferentialimpairmentofpupilconstrictionstimulatedbybluelightinpatientswithtype2diabeteswithoutautonomicneuropathy
AT mikitaniguchi preferentialimpairmentofpupilconstrictionstimulatedbybluelightinpatientswithtype2diabeteswithoutautonomicneuropathy
AT aikokosaka preferentialimpairmentofpupilconstrictionstimulatedbybluelightinpatientswithtype2diabeteswithoutautonomicneuropathy
AT harumiuetake preferentialimpairmentofpupilconstrictionstimulatedbybluelightinpatientswithtype2diabeteswithoutautonomicneuropathy
AT mitratavakoli preferentialimpairmentofpupilconstrictionstimulatedbybluelightinpatientswithtype2diabeteswithoutautonomicneuropathy